Investegate |Ellume Health; Cambridge Consu Announcements | Ellume Health; Cambridge Consu: Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume's Rapid Antigen COVID-19 Test
Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test CAMBRIDGE, United Kingdom and BRISBANE, Australia, March 10, 2021 (GLOBE NEWSWIRE) -- Today, digital diagnostics company Ellume highlights the revolutionary technology created in partnership with global product development and technology consultancy firm, Cambridge Consultants, part of the Capgemini Group. Together, the two companies have developed a next-gener...